-
REAL-WORLD DEMOGRAPHIC AND TREATMENT CHARACTERISTICS OF PATIENTS WITH CONGENITAL MYASTHENIC SYNDROME IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF BIOLOGIC THERAPIES FOR SEVERE ASTHMA: A SYSTEMATIC LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
COPULA-BASED ANALYSISOF MULTI-DOMAINHEALTH-RELATEDQUALITY OF LIFE (HRQOL)INCRIMINAL-LEGALSYSTEMINVOLVED POPULATIONS
Mar 18, 2026, 21:38 PM -
A HOSPITAL-LEVEL COST CALCULATOR COMPARING RUBIDIUM POSITRON EMISSION TOMOGRAPHY (PET) AND FLURPIRIDAZ PET FOR MYOCARDIAL PERFUSION IMAGING: A CONCEPTUAL FRAMEWORK
Mar 18, 2026, 21:38 PM -
USE OF ITEM RESPONSE THEORY TO CREATE MULTI-DIMENSIONAL MEASURES OF FINANCIAL TOXICITY IN CANCER
Mar 18, 2026, 21:38 PM -
AN ALGORITHM TO IDENTIFY LESS INVASIVE SURFACTANT ADMINISTRATION USING A REAL-WORLD DATABASE OF PRETERM INFANTS
Mar 18, 2026, 21:38 PM -
EFFICACY AND MARKET SHARE OF GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONISTS FOR CURRENT OFF-LABEL USES: A TARGETED LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
HEALTH RELATED QUALITY OF LIFE IN ULCERATIVE COLITIS: A SYSTEMATIC EVALUATION OF INSTRUMENTS AND THEIR PSYCHOMETRIC VALIDATION
Mar 18, 2026, 21:38 PM -
THE COST-EFFECTIVENESS OF INCLUSION OF JERYL LYNN MUMPS VACCINE IN THE MEASLES-RUBELLA ROUTINE IMMUNISATION SCHEDULE AMONG CHILDREN IN INDIA
Mar 18, 2026, 21:38 PM -
COMPARING SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS (SGLT2I) VERSUS RENIN-ANGIOTENSIN SYSTEM INHIBITOR (RASI) IN HEART FAILURE PATIENTS WITH ALZHEIMER’S DISEASE AND RELATED DEMENTIA (ADRD)
Mar 18, 2026, 21:38 PM -
LIVING COST-EFFECTIVENESS SEQUENCE ANALYSIS (SEQUENCE-CEA) FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A PAYER-CENTRIC FRAMEWORK FOR DYNAMIC FORMULARY DECISION MAKING
Mar 18, 2026, 21:38 PM -
THE IMPACT OF PHYSICAL FUNCTION ON HEALTHCARE RESOURCE USE AND CLINICAL OUTCOMES IN PATIENTS WITH HEART FAILURE: A UK BIOBANK STUDY
Mar 18, 2026, 21:38 PM -
CLINICAL VALIDATION OF A MACHINE-LEARNING-ENRICHED IMMUNE-MEDIATED NECROTIZING MYOPATHY COHORT USING LINKED LABORATORY AND CLAIMS DATA
Mar 18, 2026, 21:38 PM -
ASSESSING CONCENTRATION IN THE MONOCLONAL ANTIBODY INNOVATION MARKET: A PATENT-BASED STUDY
Mar 18, 2026, 21:38 PM -
CARBON AVOIDANCE: A COMPARISON OF SURGICAL APPROACHES
Mar 18, 2026, 21:38 PM -
FROM INCORPORATION TO IMPACT: REAL-WORLD BUDGET ADVANTAGE OF CLADRIBINE IN MULTIPLE SCLEROSIS WITHIN A BRAZILIAN PRIVATE HEALTH PLAN
Mar 18, 2026, 21:38 PM -
ASSOCIATION OF MARIJUANA USE AND HEALTH-RELATED QUALITY OF LIFE AMONG CARDIOVASCULAR DISEASE PATIENTS. EVIDENCE FROM THE BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM
Mar 18, 2026, 21:38 PM -
DIGITAL TOOL FOR TECHNICAL EVALUATION OF SINGLE-USE MEDICAL DEVICES IN MERCOSUR PUBLIC PROCUREMENT
Mar 18, 2026, 21:38 PM -
TRIALMAP: AN END-TO-END SOLUTION FOR MODERN CLINICAL TRIALS DESIGN WITH RWD AND AI
Mar 18, 2026, 21:38 PM -
PROMISE OF REAL-WORLD DATA NETWORKS: INNOVATIONS IN TRIAL DESIGN USING PCORNET®
Mar 18, 2026, 21:38 PM
